Biotech

All Articles

AstraZeneca pays out CSPC $100M for preclinical heart disease medication

.AstraZeneca has paid off CSPC Pharmaceutical Group $one hundred thousand for a preclinical heart at...

Zephyrm looks for Hong Kong IPO to cash stage 3 tissue therapy tests

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, declaring (PDF) for an ...

Frazier Life Sciences collects $630M for little, mid-cap biotechs

.Frazier Daily life Sciences has actually sourced a better $630 million for its own fund paid attent...

GigaGen achieves around $135M BARDA dollars to hammer botox

.Antitoxin fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own technicia...

GPCR firm Septerna apply for IPO on durability of preclinical records

.Septerna will determine exactly how a biotech without "any kind of relevant medical data" meals in ...

Kurma finalizes initially $154M haul for most significant biotech fund as yet

.International VC firm Kurma Allies has introduced its most recent biotech fund, along with 140 thou...

Prothena advertises one exec while an additional keeps-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable management hirings, firings as wel...

Editas exploit Tip Cas9 licensing liberties for $57M

.Against the scenery of a Cas9 patent fight that refuses to pass away, Editas Medicine is actually m...

Ultragenyx adjusts gene therapy application to call up effectiveness

.A minority of patients taking Ultragenyx Drug's Wilson condition gene treatment UX701 have actually...

Biopharma unemployment price maintains in Q3: Intense Biotech review

.As summer season warm looks to cool winds, really hopes that this year will deliver extensive indus...